Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions

Author： Trog D. Moenkemann H. Breipohl W. Schueller H. Schild H. Golubnitschaja O.

Publisher： Springer Publishing Company

ISSN： 0939-4451

Source： Amino Acids, Vol.32, Iss.3, 2007-04, pp. : 373-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

p27 Modulates Cell Cycle Progression and Chemosensitivity in Human Malignant Glioma

By Naumann U. Weit S. Rieger L. Meyermann R. Weller M.

Biochemical and Biophysical Research Communications, Vol. 261, Iss. 3, 1999-08 ,pp. : 890-896

Elsevier

Access to resources Recommend Favorite

Dendritic cells for treatment of human malignant brain tumours

By Rainov Nikolai G Söling Ariane

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 235-236

Informa Healthcare

Access to resources Recommend Favorite

Cell Cycle Control of Embryonic Stem Cells

By White Josephine Dalton Stephen

Stem Cell Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 131-138

Humana Press, Inc

Access to resources Recommend Favorite

A short low-level exposure to metavanadate during a cell cycle-specific interval of time is sufficient to permanently derange the differentiative properties of Mel cells

By Foresti M. Scippa S. Mele F. Palladino G. de Vincentiis M.

Mutagenesis, Vol. 16, Iss. 5, 2001-09 ,pp. : 395-400

Oxford University Press

Access to resources Recommend Favorite

Dendritic cell-based active specific immunotherapy for malignant glioma

By Parajuli Prahlad Mathupala Saroj Mittal Sandeep Sloan Andrew E

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 439-448

Informa Healthcare

Access to resources Recommend Favorite